Adenovirus vectors for gene transduction into mobilized blood CD34+ cells

被引:35
|
作者
Bregni, M
Shammah, S
Malaffo, F
Di Nicola, M
Milanesi, M
Magni, M
Matteucci, P
Ravagnani, F
Jordan, CT
Siena, S
Gianni, AM
机构
[1] Ist Nazl Tumori, Div Med Oncol, Cristina Gandini Transplant Unit, I-20133 Milan, Italy
[2] Ist Nazl Tumori, Div Immunohematol, I-20133 Milan, Italy
[3] Somatix Therapy Corp, Alameda, CA USA
关键词
CD34(+) blood cells; adenovirus vectors; gene transfer;
D O I
10.1038/sj.gt.3300620
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mobilized blood CD34(+) cells from cancer patients were ex vivo infected by a recombinant adenovirus vector carrying an alkaline phosphatase gene, whose expression is evaluable by flow cytometry. A mean of 40% CD34(+) cells were infected by the vector, with high levels of expression of the transgene. Among attempts to improve infection efficiency by manipulating culture conditions, only reinfection by the same vector achieved a 10% increase of transgene expression. Transduced CD34(+) cells were induced to differentiate along the myeloid and the dendritic lineage, and in either case AP(+) cells were detectable among the differentiated cell population. We conclude that adenovirus vectors may be useful tools for gene transduction into mobilized blood CD34(+) cells, particularly for those applications in which high transgene expression for limited periods of time is required.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 50 条
  • [21] Overexpression of gibbon ape leukemia virus (GALV) receptor (GLVR1) on human CD34+ cells increases gene transfer mediated by GALV pseudotyped vectors
    Relander, T
    Brun, ACM
    Olsson, K
    Pedersen, L
    Richter, J
    MOLECULAR THERAPY, 2002, 6 (03) : 400 - 406
  • [22] Human primary CD34+ cells transplantation for critical limb ischemia
    Lian, Weishuai
    Hu, Xiaoxiao
    Pan, Long
    Han, Shilong
    Cao, Chuanwu
    Jia, Zhongzhi
    Li, Maoquan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2018, 32 (08)
  • [23] Retroviral transduction of human CD34+ cells on fibronectin fragment CH-296 is inhibited by high concentrations of vector containing medium
    Relander, T
    Brun, A
    Hawley, RG
    Karlsson, S
    Richter, J
    JOURNAL OF GENE MEDICINE, 2001, 3 (03) : 207 - 218
  • [24] Enhanced transgene expression in cord blood CD34+-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified TRIP lentiviral vectors
    Sirven, A
    Ravet, E
    Charneau, P
    Zennou, V
    Coulombel, L
    Guétard, D
    Pflumio, F
    Dubart-Kupperschmitt, A
    MOLECULAR THERAPY, 2001, 3 (04) : 438 - 448
  • [25] Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells
    Relander, T
    Johansson, M
    Olsson, K
    Ikeda, Y
    Takeuchi, Y
    Collins, M
    Richter, J
    MOLECULAR THERAPY, 2005, 11 (03) : 452 - 459
  • [26] Efficiency of transgenic T cell generation from gene-marked cultured human CD34+ cord blood cells is determined by their maturity and the cytokines present in the culture medium
    B Verhasselt
    E Naessens
    M De Smedt
    J Plum
    Gene Therapy, 2000, 7 : 830 - 836
  • [27] Efficiency of transgenic T cell generation from gene-marked cultured human CD34+ cord blood cells is determined by their maturity and the cytokines present in the culture medium
    Verhasselt, B
    Naessens, E
    De Smedt, M
    Plum, J
    GENE THERAPY, 2000, 7 (10) : 830 - 836
  • [28] Prolonged high-level detection of retrovirally marked hematopoietic cells in nonhuman primates after transduction of CD34+ progenitors using clinically feasible methods
    Wu, T
    Kim, HJ
    Sellers, SE
    Meade, KE
    Agricola, BA
    Metzger, ME
    Kato, I
    Donahue, RE
    Dunbar, CE
    Tisdale, JF
    MOLECULAR THERAPY, 2000, 1 (03) : 285 - 293
  • [29] Hexon modification of human adenovirus type 5 vectors enables efficient transduction of human multipotent mesenchymal stromal cells
    Nilson, Robin
    Luebbers, Olivia
    Schmidt, Christoph Q.
    Rojewski, Markus
    Zeplin, Philip Helge
    Funk, Wolfgang
    Schrezenmeier, Hubert
    Kritzinger, Astrid
    Kochanek, Stefan
    Krutzke, Lea
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 25 : 96 - 110
  • [30] Restriction of transgene expression to the B-lymphoid progeny of human lentivirally transduced CD34+ cells
    Moreau, T
    Bardin, F
    Imbert, J
    Chabannon, C
    Tonnelle, C
    MOLECULAR THERAPY, 2004, 10 (01) : 45 - 56